Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SHE: 300760)

Shenzhen Mindray Bio-Medical Electronics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	20,599	18,787	23,186	15,361	15,865	14,273
Cash & Short-Term Investments	20,787	18,787	23,186	15,361	15,865	14,273
Cash Growth	2.91%	-18.97%	50.94%	-3.17%	11.15%	23.64%
Accounts Receivable	4,025	3,297	2,661	1,790	1,539	1,695
Other Receivables	252.59	195.1	149.11	126.04	279.03	244.74
Receivables	4,318	3,534	2,842	1,943	1,842	1,960
Inventory	4,520	3,979	4,025	3,565	3,617	2,265
Prepaid Expenses	63.65	60.57	92.31	58.1	123.87	26.41
Other Current Assets	637.9	515.29	461.19	407.58	183.29	200.48
Total Current Assets	30,327	26,875	30,606	21,335	21,632	18,724
Property, Plant & Equipment	9,312	8,221	6,290	5,131	4,129	3,659
Long-Term Investments	414.73	3,087	1,617	4,026	4,026	5
Goodwill	11,147	5,062	4,403	4,218	1,225	1,301
Other Intangible Assets	6,650	2,225	1,977	2,061	1,145	953.48
Long-Term Accounts Receivable	10.97	10.94	25.28	34.55	3.32	15.63
Long-Term Deferred Tax Assets	1,280	1,313	755.08	596.43	501.89	457.19
Long-Term Deferred Charges	412.68	417.23	379.45	224.24	204.16	167.13
Other Long-Term Assets	948.32	604	590.95	376.65	337.3	270.25
Total Assets	60,626	47,940	46,745	38,103	33,306	25,634
Accounts Payable	3,880	2,690	2,291	2,281	1,500	1,244
Accrued Expenses	4,492	3,139	3,136	2,428	2,063	1,386
Short-Term Debt	3.48	7.75	-	-	-	-
Current Portion of Long-Term Debt	1.83	0.43	-	-	-	-
Current Portion of Leases	108.28	104.3	97.22	85.08	-	-
Current Income Taxes Payable	468.99	471.65	287.22	256.75	136.31	98.26
Current Unearned Revenue	2,087	1,974	4,143	2,408	3,293	-
Other Current Liabilities	1,864	1,715	1,816	1,170	1,244	2,314
Total Current Liabilities	12,905	10,103	11,770	8,629	8,236	5,043
Long-Term Debt	0.39	1.38	-	-	-	-
Long-Term Leases	183.92	181.07	139.31	152.15	-	-
Long-Term Unearned Revenue	132.38	109.31	92.94	105.09	156.79	379.53
Long-Term Deferred Tax Liabilities	860.84	168.36	183.13	200.44	46.62	57.25
Other Long-Term Liabilities	2,890	4,031	2,561	2,048	1,576	1,537
Total Liabilities	16,973	14,594	14,746	11,135	10,016	7,017
Common Stock	1,212	1,212	1,212	1,216	1,216	1,216
Additional Paid-In Capital	6,909	7,091	7,509	8,153	8,153	8,171
Retained Earnings	31,030	25,288	24,369	18,994	14,032	9,207
Treasury Stock	-328.44	-663.28	-999.99	-999.99	-	-
Comprensive Income & Other	24.21	157.27	-109.07	-409.74	-122.58	-1.31
Total Common Equity	38,848	33,085	31,981	26,953	23,278	18,593
Minority Interest	4,805	260.65	18.29	15.24	12.75	23.94
Shareholders' Equity	43,653	33,346	31,999	26,968	23,290	18,617
Total Liabilities & Equity	60,626	47,940	46,745	38,103	33,306	25,634
Total Debt	297.9	294.93	236.52	237.24	-	-
Net Cash (Debt)	20,489	18,492	22,949	15,124	15,865	14,273
Net Cash Growth	2.67%	-19.42%	51.74%	-4.67%	11.15%	23.64%
Net Cash Per Share	16.91	15.26	18.96	12.45	13.05	11.74
Filing Date Shares Outstanding	1,211	1,214	1,209	1,213	1,216	1,216
Total Common Shares Outstanding	1,211	1,214	1,209	1,213	1,216	1,216
Working Capital	17,421	16,773	18,836	12,706	13,395	13,681
Book Value Per Share	32.07	27.25	26.44	22.23	19.15	15.29
Tangible Book Value	21,050	25,799	25,601	20,673	20,908	16,339
Tangible Book Value Per Share	17.38	21.25	21.17	17.05	17.20	13.44
Land	5,440	4,799	3,662	3,259	2,876	2,394
Machinery	3,790	3,283	2,822	2,366	1,924	1,715
Construction In Progress	2,602	2,461	1,803	1,126	929.84	975.17

Source: S&P Capital IQ. Standard template. Financial Sources.